Bristol-Myers Squibb
A BioPharma Leader
Bristol-Myers Squibb is a global BioPharma company firmly focused on itsMission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Around the world, our medicines help millions of people in their fight against such diseases as cancer, cardiovascular disease, diabetes, hepatitis B, HIV/AIDS, rheumatoid arthritis and psychiatric disorders.
Sort by
Entecavir(abbr. ETV) (INN) (pronounced /ɛnˈtɛkəvɪər/) is an oral antiviral drug used in the treatment of hepatitis B infection. It is marketed under the trade name Baraclude (BMS).
1102.23 (USD)
847.87 (USD)
|
Fungizone
Intravenous Injectable vial
50 Mg amphotericin sterile pyrogen.
|
Dasatinib, previously known as BMS-354825, is a cancer drug produced by Bristol-Myers Squibb and sold under the trade name Sprycel.
9798.70 (USD)
7537.46 (USD)
|